Literature DB >> 11681204

Construction of a Francisella tularensis two-dimensional electrophoresis protein database.

L Hernychová1, J Stulík, P Halada, A Macela, M Kroca, T Johansson, M Malina.   

Abstract

We have started the construction of a two-dimensional database of the proteome of Francisella tularensis, a bacterium that is responsible for the highly pathogenic disease tularemia. The genome of this intracellular pathogen is not completely sequenced yet and, currently, information about only 66 proteins is available from NCBI database. We have analyzed the F. tularensis live vaccine strain by two-dimensional gel electrophoresis with immobilized pH 3-10 gradient in the first dimension and 9-16% gradient or tricine SDS-PAGE in the second dimension. In both cases about 2000 spots were detected. Furthermore, we compared the protein pattern of the nonvirulent F. tularensis live vaccine strain with protein profiles of two wild type clinical isolates and more than 50 differentially expressed proteins were counted. The separated proteins are going to be identified by peptide mass fingerprinting. However, due to the lack of complete genome sequence data only eight proteins were unambiguously identified. Among them, acid phosphatase and the most basic isoform of a hypothetical 23 kDa protein are characteristic only for virulent strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681204     DOI: 10.1002/1615-9861(200104)1:4<508::AID-PROT508>3.0.CO;2-K

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis.

Authors:  Ramona L McCaffrey; Justin T Schwartz; Stephen R Lindemann; Jessica G Moreland; Blake W Buchan; Bradley D Jones; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

2.  Inhibition of AcpA phosphatase activity with ascorbate attenuates Francisella tularensis intramacrophage survival.

Authors:  Steven McRae; Fernando A Pagliai; Nrusingh P Mohapatra; Alejandro Gener; Asma Sayed Abdelgeliel Mahmou; John S Gunn; Graciela L Lorca; Claudio F Gonzalez
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

3.  Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain.

Authors:  George Aperis; Beth Burgwyn Fuchs; Christine A Anderson; John E Warner; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Microbes Infect       Date:  2007-02-24       Impact factor: 2.700

4.  Comparative Analysis of Proteome Patterns of Francisella tularensis Isolates from Patients and the Environment.

Authors:  Murat Kasap; Aynur Karadenizli; Gürler Akpınar; Hüseyin Uzuner; Abula Ayimugu; Kübra Karaosmanoğlu; Doğanhan Kadir Er
Journal:  Curr Microbiol       Date:  2016-12-19       Impact factor: 2.188

5.  Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS.

Authors:  Grant S Schulert; Ramona L McCaffrey; Blake W Buchan; Stephen R Lindemann; Clayton Hollenback; Bradley D Jones; Lee-Ann H Allen
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

6.  Modulation of virulence factors in Francisella tularensis determines human macrophage responses.

Authors:  Paul E Carlson; James A Carroll; Dawn M O'Dee; Gerard J Nau
Journal:  Microb Pathog       Date:  2007-02-15       Impact factor: 3.738

7.  A European pathogenic microorganism proteome database: construction and maintenance.

Authors:  Klaus-Peter Pleissner; Till Eifert; Peter R Jungblut
Journal:  Comp Funct Genomics       Date:  2002

Review 8.  Proteomics for biodefense applications: progress and opportunities.

Authors:  Richard R Drake; Yuping Deng; E Ellen Schwegler; Stefan Gravenstein
Journal:  Expert Rev Proteomics       Date:  2005-04       Impact factor: 3.940

9.  Tularemia induces different biochemical responses in BALB/c mice and common voles.

Authors:  Hana Bandouchova; Jana Sedlackova; Miroslav Pohanka; Ladislav Novotny; Martin Hubalek; Frantisek Treml; Frantisek Vitula; Jiri Pikula
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.